Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Lucid Diagnostics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
LUCD
Nasdaq
3841
https://www.luciddx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Lucid Diagnostics Inc
PAVmed Inc. (NASDAQ:PAVM) Q4 2022 Earnings Call Transcript
- Mar 21st, 2023 1:03 am
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2022 Earnings Call Transcript
- Mar 17th, 2023 8:15 am
Q4 2022 PAVmed Inc Earnings Call
- Mar 16th, 2023 5:22 am
Q4 2022 Lucid Diagnostics Inc Earnings Call
- Mar 15th, 2023 6:43 am
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results
- Mar 14th, 2023 11:09 pm
/C O R R E C T I O N -- Lucid Diagnostics/
- Mar 14th, 2023 5:28 pm
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023
- Mar 3rd, 2023 1:15 pm
PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023
- Mar 3rd, 2023 1:15 pm
PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform™ Goes Live
- Feb 28th, 2023 1:30 pm
Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event
- Feb 15th, 2023 1:30 pm
PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs
- Jan 18th, 2023 11:24 am
PAVmed and Lucid Diagnostics Provide Strategic Business Update
- Jan 17th, 2023 9:05 pm
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
- Jan 11th, 2023 1:00 pm
PAVmed Partners with Novosound on Ultrasound Imaging Technology
- Dec 22nd, 2022 1:25 pm
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
- Dec 15th, 2022 1:25 pm
Here's Why Lucid Diagnostics (NASDAQ:LUCD) Must Use Its Cash Wisely
- Dec 12th, 2022 1:43 pm
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
- Dec 8th, 2022 1:25 pm
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
- Dec 1st, 2022 1:25 pm
PAVmed Provides Business Update and Third Quarter 2022 Financial Results
- Nov 15th, 2022 9:20 pm
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
- Nov 14th, 2022 9:40 pm
Scroll